Additional Information

Dr. Ian Goldlust is a physician-scientist and fellow in medical oncology at the NCI focusing on adoptive cell therapies for ovarian cancer. He earned his PhD through the OxCam program—a collaboration between NIH-NCATS and the University of Cambridge—in the labs of Drs. James Brenton and Craig Thomas. He subsequently completed his medical training and internal medicine residency at Columbia University prior to joining the Rosenberg lab. Here, he develops peritoneal directed, tumor infiltrating lymphocytes for the treatment of high-grade serous ovarian cancer.